{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/70954-522#drug","name":"INZIRQO","alternateName":"hydrochlorothiazide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"70954-522"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA219141"},{"@type":"PropertyValue","propertyID":"UNII","value":"0J48LPH2TH"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"41aaea48-6c1b-42c8-a96f-5923d49dc934"}],"activeIngredient":"HYDROCHLOROTHIAZIDE","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SUSPENSION","manufacturer":{"@type":"Organization","name":"ANI Pharmaceuticals, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA219141","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41aaea48-6c1b-42c8-a96f-5923d49dc934","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70954-522"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T06:15:40.756Z"}}